|Landscape of somatic mutations in 560 breast cancer whole-genome sequences|
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
|Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for …|
IF Khouri, M Keating, M Körbling, D Przepiorka, P Anderlini, S O'Brien, ...
Journal of Clinical Oncology 16 (8), 2817-2824, 1998
|Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell …|
S Giralt, PF Thall, I Khouri, X Wang, I Braunschweig, C Ippolitti, D Claxton, ...
Blood, The Journal of the American Society of Hematology 97 (3), 631-637, 2001
|Bone imaging in metastatic breast cancer|
T Hamaoka, JE Madewell, DA Podoloff, GN Hortobagyi, NT Ueno
Journal of Clinical Oncology 22 (14), 2942-2953, 2004
|Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes|
H Masuda, KA Baggerly, Y Wang, Y Zhang, AM Gonzalez-Angulo, ...
Clinical cancer research 19 (19), 5533-5540, 2013
|A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer|
C Hatzis, L Pusztai, V Valero, DJ Booser, L Esserman, A Lluch, T Vidaurre, ...
Jama 305 (18), 1873-1881, 2011
|Role of epidermal growth factor receptor in breast cancer|
H Masuda, D Zhang, C Bartholomeusz, H Doihara, GN Hortobagyi, ...
Breast cancer research and treatment 136 (2), 331-345, 2012
|International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment|
S Dawood, SD Merajver, P Viens, PB Vermeulen, SM Swain, TA Buchholz, ...
Annals of oncology 22 (3), 515-523, 2011
|Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term …|
M De Lima, A Anagnostopoulos, M Munsell, M Shahjahan, N Ueno, ...
Blood 104 (3), 865-872, 2004
|Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors|
N Niikura, J Liu, N Hayashi, EA Mittendorf, Y Gong, SL Palla, Y Tokuda, ...
Journal of Clinical Oncology 30 (6), 593, 2012
|P27kip1 down-regulation is associated with trastuzumab resistance in breast cancer cells|
R Nahta, T Takahashi, NT Ueno, MC Hung, FJ Esteva
Cancer research 64 (11), 3981-3986, 2004
|Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and …|
IF Khouri, P McLaughlin, RM Saliba, C Hosing, M Korbling, MS Lee, ...
Blood, The Journal of the American Society of Hematology 111 (12), 5530-5536, 2008
|Inflammatory breast cancer: the disease, the biology, the treatment|
FM Robertson, M Bondy, W Yang, H Yamauchi, S Wiggins, S Kamrudin, ...
CA: a cancer journal for clinicians 60 (6), 351-375, 2010
|Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.|
NT Ueno, G Rondón, NQ Mirza, DK Geisler, P Anderlini, SA Giralt, ...
Journal of clinical oncology 16 (3), 986-993, 1998
|Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials|
F Meric-Bernstam, L Brusco, K Shaw, C Horombe, S Kopetz, MA Davies, ...
Journal of clinical oncology 33 (25), 2753, 2015
|Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint|
T Sudo, M Nitta, H Saya, NT Ueno
Cancer research 64 (7), 2502-2508, 2004
|Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation|
D Przepiorka, TL Smith, J Folloder, I Khouri, NT Ueno, R Mehra, ...
Blood, The Journal of the American Society of Hematology 94 (4), 1465-1470, 1999
|Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at MD Anderson Cancer Center|
NT Ueno, AU Buzdar, SE Singletary, FC Ames, MD McNeese, FA Holmes, ...
Cancer chemotherapy and pharmacology 40 (4), 321-329, 1997
|Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, as evolving strategy for adoptive immunotherapy|
Br J Haematol 111, 18-29, 2000
|Cationic Liposome-Mediated E1A Gene Transfer to Human Breast and Ovarian Cancer Cells and Its Biologic Effects: A Phase I Clinical Trial|
GN Hortobagyi, NT Ueno, W Xia, S Zhang, JK Wolf, JB Putnam, ...
Journal of Clinical Oncology 19 (14), 3422-3433, 2001